Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy

被引:47
|
作者
Kato, Tomoko S. [1 ]
Takayama, Hiroo [2 ]
Yoshizawa, Saeko [3 ]
Marboe, Charles [3 ]
Schulze, P. Christian [1 ]
Farr, Maryjane [1 ]
Naka, Yoshifumi [2 ]
Mancini, Donna [1 ]
Maurer, Mathew S. [1 ]
机构
[1] Columbia Univ, Dept Med, Div Cardiol, Med Ctr, New York, NY 10027 USA
[2] Columbia Univ, Dept Surg, Div Cardiothorac Surg, Med Ctr, New York, NY USA
[3] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2012年 / 110卷 / 04期
关键词
MUSCLE CELL DISORGANIZATION; LEFT-VENTRICULAR HYPERTROPHY; HEART-TRANSPLANTATION; CLINICAL-SIGNIFICANCE; ATHLETES HEART; SURVIVAL; PREVALENCE; INFECTION; DIAGNOSIS; FEATURES;
D O I
10.1016/j.amjcard.2012.04.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac transplantation is a treatment option for patients with hypertrophic cardiomyopathy (HC) who developed refractory heart failure and/or intractable arrhythmia. However, the pretransplant characteristics and post-transplant prognosis for patients with nondilated idiopathic HC has not yet fully elucidated. Therefore, we retrospectively reviewed 813 consecutive transplant recipients undergoing cardiac transplantation at Columbia University Medical Center from 1999 to 2010 and compared the clinical course of 41 patients with idiopathic HC with that of 373 patients with ischemic heart disease and 398 patients with other heart disease. The patients with HC were younger than those with ischemic heart disease (47.8 +/- 14.0 vs 57.1 +/- 9.4 years; p <0.0001). The proportion of patients undergoing ventricular assist devise surgery for bridge-to-transplant was lower in patients with HC than in those with ischemic heart disease or other heart disease (14.6% vs 31.1% vs 35.7%, all p <0.01). The post-transplant survival of those with HC was better than that for those with ischemic heart disease (90.1% vs 85.8% and 83.9% vs 67.1% at 1 and 5 years, respectively; p = 0.0359), although it was not significantly different from those with other heart disease. Proportional hazards analysis revealed that the subjects with HC had reduced post-transplant mortality (hazard ratio 0.4760, 95% confidential interval 0.1889 to 0.9762; p = 0.042) on univariate, but not multivariate, analysis. Most patients with HC had nondilated left ventricles (left ventricular end-diastolic dimension <= 55 mm; n = 27), and post-transplant survival did not differ from that for those with dilated left ventricles (left ventricular end-diastolic dimension >55 mm; n = 14). In conclusion, the post-transplant survival of those with HC did not differ from those of the subjects who underwent transplant for other non-HC indications. (C) 2012 Elsevier Inc. All rights reserved. (Am J Cardiol 2012;110:568-574)
引用
收藏
页码:568 / 574
页数:7
相关论文
共 50 条
  • [1] Survival After Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy
    Maron, Martin S.
    Kalsmith, Benjamin M.
    Udelson, James E.
    Li, Wenjun
    DeNofrio, David
    CIRCULATION-HEART FAILURE, 2010, 3 (05) : 574 - 579
  • [2] Hypertrophic Cardiomyopathy in Liver Transplantation Patients
    Pai, S-L
    Aniskevich, S., III
    Logvinov, I. I.
    Matcha, G., V
    Palmer, W. C.
    Blackshear, J. L.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (05) : 1466 - 1469
  • [3] Cardiac transplantation for hypertrophic cardiomyopathy: A valid therapeutic option
    Coutu, M
    Perrault, LP
    White, M
    Pelletier, GB
    Racine, N
    Poirier, NC
    Carrier, M
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (04): : 413 - 417
  • [4] CLINICOPATHOLOGICAL FEATURES OF HYPERTROPHIC CARDIOMYOPATHY MANAGED BY CARDIAC TRANSPLANTATION
    SHIRANI, J
    MARON, BJ
    CANNON, RO
    SHAHIN, S
    ROBERTS, WC
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (05): : 434 - 440
  • [5] Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy
    Waller, TA
    Hiser, WL
    Capehart, JE
    Roberts, WC
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (07): : 884 - 894
  • [6] The Outcome of Patients with Idiopathic Non-Dilated Hypertrophic Cardiomyopathy Following Cardiac Transplantation
    Kato, T. S.
    Maurer, M.
    Naka, Y.
    Farr, M.
    Mancini, D.
    Schulze, P. C.
    Takayama, H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S158 - S159
  • [7] Cardiac natriuretic peptides in patients with hypertrophic cardiomyopathy
    Safrygina, Yu V.
    Gabrusenko, S. A.
    Ovchinnikov, A. G.
    Masenko, V. P.
    Naumov, V. G.
    Ageev, F. T.
    Belenkov, Yu N.
    KARDIOLOGIYA, 2007, 47 (05) : 50 - 57
  • [8] Noninvasive cardiac imaging in patients with hypertrophic cardiomyopathy
    Nagueh, Sherif F.
    Mahmarian, John J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (12) : 2410 - 2422
  • [9] Cardiac Rehabilitation for Patients With Idiopathic Hypertrophic Cardiomyopathy
    Nakayama, Atsuko
    Morita, Hiroyuki
    Kato, Yuko
    Komuro, Issei
    Isobe, Mitsuaki
    CIRCULATION, 2021, 144
  • [10] Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy
    Vatutin, N. T.
    Taradin, G. G.
    Maron, M. S.
    Shevelek, A. N.
    KARDIOLOGIYA, 2016, 56 (01) : 56 - 65